Prognostic value of diagnostic criteria for familial hypercholesterolemia in men and women with dyslipidemia

QR Code

Prognostic value of diagnostic criteria for familial hypercholesterolemia in men and women with dyslipidemia

Aim. To analyze the prognostic value of the Dutch Lipid Clinic Network (DLCN) and Simon Broome Register (SBR) screening criteria for familial hypercholesterolemia (FH) in men and women with dyslipidemia.Material and methods. The study included 1233 patients with dyslipidemia.Biomaterial samples from...

Full description

Saved in:

Bibliographic Details
Main Authors:	Z. F. Kim, A. S. Galyavich, D. I. Sadykova, L. M. Nurieva
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2023-12-01
Series:	Российский кардиологический журнал
Subjects:	lipid metabolism disorder familial hypercholesterolemia gene mutations diagnostic criteria
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/5701
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Possibilities of lipid clinics in identifying patients with familial hypercholesterolemia
by: Z. F. Kim, et al.
Published: (2023-03-01)

Phenotypical features of heterozygous familial hypercholesterolemia in individuals with LDLR or APOB gene mutations
by: A. N. Meshkov, et al.
Published: (1970-01-01)

Diagnostic Characteristics of Familial Hypercholesterolemia in Children
by: Dinara I. Sadykova, et al.
Published: (2020-06-01)

FAMILIAL HYPERCHOLESTEROLEMIA: DIAGNOSTIC ISSUES AND THERAPEUTIC POSSIBILITIES
by: Vitalii K. Zafiraki, et al.
Published: (2019-03-01)

EXPERIENCE WITH THE USE OF EVOLOCUMAB THERAPY IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (IN KARELIA REPUBLIC)
by: V. A. Korneva, et al.
Published: (2020-06-01)

Familial Hypercholesterolemia in Children. The Current State of the Problem
by: Dinara I. Sadykova, et al.
Published: (2023-07-01)

Analysis of the low density lipoprotein receptor gene (<i>LDLR</i>) mutation spectrum in Russian familial hypercholesterolemia
by: V. B. Vasilyev, et al.
Published: (2022-06-01)

Familial hypercholesterolemia: current status of the problem, treatment, and prevention
by: S. A. Bliznyuk, et al.
Published: (2020-11-01)

ANALYSIS OF THE TRADITIONAL RISK FACTORS INFLUENCE ON DEVELOPMENT OF ISCHEMIC HEART DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA
by: V. A. Korneva, et al.
Published: (2017-06-01)

Cardiovascular disease and compliance with lipid-lowering therapy among young individuals with familial hypercholesterolemia in Norway – A register study
by: Gisle Langslet, et al.
Published: (2025-09-01)

VARIABILITY IN LEVELS OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA DEPENDING ON AGE AND SEX AND ITS IMPORTANCE IN THE DIAGNOSIS OF THIS DISEASE
by: V. А. Korneva, et al.
Published: (2017-03-01)

Coronary heart disease development in heterozygotic form of familial hypercholesterolemia
by: P. P. Malyshev, et al.
Published: (2006-10-01)

Impact of hyperlipoproteinemia(a) on the diagnosis of familial hypercholesterolemia and cardiovascular risk assessment
by: A. M. Namitokov, et al.
Published: (2025-04-01)

Ultrasound examination of achilles tendons in patients with familial hypercholesterolemia
by: V. V. Genkel, et al.
Published: (2018-09-01)

RUSSIAN GUIDELINES ON FAMILIAL HYPERCHOLESTEROLEMIA DIAGNOSIS AND TREATMENT
by: article Editorial
Published: (2017-06-01)

Modern ultrasound methods and atherosclerosis assessment in patients with familial hypercholesterolemia
by: A. I. Ershova, et al.
Published: (2011-06-01)

Prevalence of familial hypercholesterolemia and hyperlipoproteinemia(a) in patients with premature acute coronary syndrome
by: U. V. Chubykina, et al.
Published: (2022-07-01)

LIPOPROTEIN(A) MEANING AS AN ADDITIONAL MARKER OF CARDIOVASCULAR RISK IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
by: V. A. Korneva, et al.
Published: (2016-06-01)

Familial hypercholesterolemia: case series of a rare condition
by: O. P. Ishevskaia, et al.
Published: (2021-10-01)

CASCADE GENETIC SCREENING IN DIAGNOSTICS OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: CLINICAL CASE
by: E. V. Shakhtshneider, et al.
Published: (2017-07-01)

SUBFRACTIONS OF ATHEROGENIC APOB-LIPOPROTEIDES IN PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA
by: E. A. Utkina, et al.
Published: (2017-08-01)

IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION
by: I. V. Sergienko, et al.
Published: (2018-03-01)

CLINICAL APPLICATION OF HELP-APHERESIS IN FEMALE PATIENT WITH FAMILIAL HYPERCHOLESTEROLEMIA
by: OLGA L. Barbarash, et al.
Published: (2018-12-01)

Clinical features and genetic analysis of a Brazilian patient with sitosterolemia: a case report
by: Felipe Augusto Azevedo Leão, et al.
Published: (2025-06-01)

Register of patients with familial hypercholesterolemia and patients of very high cardiovascular risk with lipid-lowering therapy underperformance (RENESSANS)
by: M. V. Yezhov, et al.
Published: (2019-06-01)

Organization of lipid centers operation in the Russian Federation — new opportunities
by: M. V. Ezhov, et al.
Published: (2021-07-01)

Analysis of risk factors for aortic stenosis in patients with familial hypercholesterolemia
by: V. A. Korneva, et al.
Published: (2025-02-01)

Use of polygenic risk scores for differential diagnostics for patients with clinical diagnosis of familial hypercholesterolemia
by: M. Zaychenoka, et al.
Published: (2025-02-01)

Advancing neuroprotection and atherosclerosis prevention through familial hypercholesterolemia management: Analyzing comorbidity burden with stroke, coronary heart disease, hypertension, and diabetes
by: Jingjia Wang, et al.
Published: (2025-03-01)

Cross-Sectional Study to Estimate the Prevalence of Familial Hypercholesterolemia in Selected Regions of the Russian Federation: Relevance, Design of the Study and Initial Characteristics of the Participants
by: A. N. Meshkov, et al.
Published: (2020-03-01)

Existing problems and new possibilities in the treatment of dyslipidemia Joint Conclusion Based on the Results of the Expert Council
by: M. V. Ezhov, et al.
Published: (2021-03-01)

New opportunities for identifying the risk of cardiovascular events in young people: the role of familial hypercholesterolemia
by: V. S. Emelyanchik, et al.
Published: (2023-01-01)

Phenotype of heterozygous familial hypercholesterolemia caused by deletion of <i>LDLR</i> gene exons 2-10: a case report
by: A. M. Moiseeva, et al.
Published: (2024-12-01)

Identification of c.683_684insCTGCAAGGACAAATCTGACGA pathogenic variant of the low-density lipoprotein receptor gene in a patient with familial hypercholesterolemia: a case report
by: V. A. Korneva, et al.
Published: (2023-09-01)

Outpatient monthly plasmapheresis with post-PLEX evinacumab in pediatric homozygous familial hypercholesterolemia: a case report on port access and immunoglobulin preservation
by: Guido Filler, et al.
Published: (2025-07-01)

Severe hyperlipoproteinemia(a) as a factor of rapidly progressive coronary artery disease in a young woman with heterozygous familial hypercholesterolemia
by: U. V. Chubykina, et al.
Published: (2019-06-01)

Hypertension and Hypercholesterolemia: is it Time for Anti-«Lipitensive» Therapy?
by: Z. D. Kobalava, et al.
Published: (2020-11-01)

Incidence of familial hypercholesterolemia in patients with early manifestations of coronary artery disease: data from a Russian multicenter study and meta-analysis
by: A. A. Rogozhina, et al.
Published: (2023-11-01)

Elevated levels of lipoprotein(a) and low-density lipoprotein cholesterol in familial hypercholesterolemia patients: is dual primary prevention already in sight?
by: Alpo Vuorio, et al.
Published: (2025-07-01)

Clinical characteristics of carriers of pathogenic LDLR and АРОВ mutations
by: Z. F. Kim, et al.
Published: (2024-02-01)